A similar study conducted in Cambodia using cohort analysis showed an increase in median CD4 counts from 53 to 316 cells/mm3, and that 68% of hypertension patients on regular treatment had their BP controlled after 2 years of implementation of the pilot study [18]. Here, CD4 is linked to hypertensive disorder.